Editorial Commentary
Sentinel lymph node biopsy in early oral cancer: interpreting high significance in low-event cohorts
Translational Cancer Research
2025;
14
(12)
:8218-8220
.
(31 December 2025)
Implementing perioperative immunotherapy for head and neck cancer after KEYNOTE-689: questions and challenges
Translational Cancer Research
2025;
14
(12)
:8221-8227
.
(31 December 2025)
Original Article
Stratifying prognosis in stage III colorectal cancer patients: the role of tumor deposits and lymph node ratio
Translational Cancer Research
2025;
14
(12)
:8228-8242
.
(31 December 2025)
5MPN effectively targets PFKFB4 and inhibits the glucose metabolism process and invasion of glioblastoma
Translational Cancer Research
2025;
14
(12)
:8243-8253
.
(31 December 2025)
Machine learning screening for disulfidptosis genes- associated immunosuppression status in osteosarcoma and rhabdomyosarcoma
Translational Cancer Research
2025;
14
(12)
:8254-8270
.
(31 December 2025)
Laparoscopic surgery is effective and safe in high-risk endometrial cancer
Translational Cancer Research
2025;
14
(12)
:8271-8284
.
(31 December 2025)
Activated RARα counteracts the effects of TACC1v25 on the differentiation and invasion of head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(12)
:8285-8300
.
(31 December 2025)
SLC25A3 promotes hepatocellular carcinoma progression by inducing mitochondrial dysfunction and chromatin remodeling
Translational Cancer Research
2025;
14
(12)
:8301-8312
.
(31 December 2025)
Targeted next-generation sequencing reveals genomic differences between male and female breast cancer
Translational Cancer Research
2025;
14
(12)
:8313-8328
.
(31 December 2025)
Research hotspots and frontiers in the tumor microenvironment of gastric cancer: a bibliometric review from 2005 to 2024
Translational Cancer Research
2025;
14
(12)
:8329-8346
.
(31 December 2025)
Development and validation of a novel palmitoylation-related prognostic signature in head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(12)
:8347-8364
.
(31 December 2025)
Molecular characterization and prognostic modeling of liquid- liquid phase separation-related genes in osteosarcoma based on single-cell sequencing and weighted gene co-expression network analysis
Translational Cancer Research
2025;
14
(12)
:8365-8384
.
(31 December 2025)
Proteomic analysis of altered urinary extracellular vesicle levels in breast cancer patients pre- and post-surgery
Translational Cancer Research
2025;
14
(12)
:8385-8403
.
(31 December 2025)
Upregulation of spondin-2 indicates poorer clinical outcomes and induces radioresistance in gastric cancer
Translational Cancer Research
2025;
14
(12)
:8404-8417
.
(31 December 2025)
Mechanistic study of LINC01296 mediating TRIP13 regulation of neuroblastoma progression
Translational Cancer Research
2025;
14
(12)
:8418-8431
.
(31 December 2025)
Examining the effectiveness of follow-up chemotherapy in large cell neuroendocrine carcinoma: special emphasis on stage T1–2N0M0 according to 9th edition TNM guidelines
Translational Cancer Research
2025;
14
(12)
:8432-8447
.
(31 December 2025)
Glutamine metabolism drives tumor aggressiveness but not chemoresistance in ovarian carcinoma cell lines
Translational Cancer Research
2025;
14
(12)
:8448-8461
.
(31 December 2025)
Interpretable LASSO-Cox model: Hsp90α/albumin ratio predicts hepatocellular carcinoma prognosis
Translational Cancer Research
2025;
14
(12)
:8462-8474
.
(31 December 2025)
The value of different machine learning radiomics based on DCE-MRI in predicting axillary lymph node status of breast cancer
Translational Cancer Research
2025;
14
(12)
:8475-8488
.
(31 December 2025)
Sarcopenia-driven gene model as a clinically actionable prognostic signature for head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(12)
:8489-8502
.
(31 December 2025)
Preoperative prediction of breast cancer Ki-67 status via multimodal ultrasound-clinical nomogram: a single-center study
Translational Cancer Research
2025;
14
(12)
:8503-8512
.
(31 December 2025)
tRF-29-86J8WPMN1EJ3: a tRNA-derived small RNA promoting esophageal cancer progression
Translational Cancer Research
2025;
14
(12)
:8513-8525
.
(31 December 2025)
LASSO-based nomograms predict early death in small cell lung cancer (SCLC) patients with brain metastasis
Translational Cancer Research
2025;
14
(12)
:8526-8541
.
(31 December 2025)
High TERF2 expression is associated with poor prognosis and its suppression attenuates progression in acute myeloid leukemia
Translational Cancer Research
2025;
14
(12)
:8542-8555
.
(31 December 2025)
Impact of underlying liver etiology on post-hepatectomy survival outcomes in hepatocellular carcinoma patients
Translational Cancer Research
2025;
14
(12)
:8556-8566
.
(31 December 2025)
Targeting the METTL3/PCNA axis with STM2457 overcomes cisplatin resistance in osteosarcoma
Translational Cancer Research
2025;
14
(12)
:8567-8578
.
(31 December 2025)
Identification of differentiation markers and immune microenvironment in head and neck squamous cell carcinoma using machine learning combined with single-cell analysis
Translational Cancer Research
2025;
14
(12)
:8579-8599
.
(31 December 2025)
Multivesicular body subunit 12B (MVB12B) overexpression represses proliferation and migration in bladder urothelial carcinoma
Translational Cancer Research
2025;
14
(12)
:8600-8615
.
(31 December 2025)
Warfarin and bevacizumab suppress tumor progression in pancreatic ductal adenocarcinoma by targeting EGFR-PI3K-Akt signaling: inhibition of proliferation/migration and apoptosis induction
Translational Cancer Research
2025;
14
(12)
:8616-8631
.
(31 December 2025)
Development and validation of a novel prognostic signature for osteosarcoma
Translational Cancer Research
2025;
14
(12)
:8632-8641
.
(31 December 2025)
Bufalin: a potential drug for regulating EGFR-TKIs resistance in lung cancer via the EGFR-PI3K/Akt-mTOR signaling
Translational Cancer Research
2025;
14
(12)
:8642-8654
.
(31 December 2025)
Association between urinary perchlorate and malignancies of endocrine-related tissues in U.S. adults: analysis of National Health and Nutrition Examination Survey (NHANES) data
Translational Cancer Research
2025;
14
(12)
:8655-8666
.
(31 December 2025)
Prognosis and chemotherapy efficacy in small-tumor breast cancer with different immune subtypes: a SEER-based study
Translational Cancer Research
2025;
14
(12)
:8667-8687
.
(31 December 2025)
Development of a fatty acid metabolism (FAM)-related gene signature for prognosis prediction and personalized therapy in lower grade gliomas
Translational Cancer Research
2025;
14
(12)
:8688-8704
.
(31 December 2025)
Prognostic implications of a programmed cell death-related long non-coding RNA signature and its relevance to immune features in esophageal carcinoma
Translational Cancer Research
2025;
14
(12)
:8705-8724
.
(31 December 2025)
Survival benefit of adjuvant chemotherapy for duodenal adenocarcinoma: a retrospective cohort study and propensity score-matched analysis
Translational Cancer Research
2025;
14
(12)
:8725-8736
.
(31 December 2025)
An immune checkpoint-based score is a prognostic marker in retrospective cohort study of patients with gastric cancer
Translational Cancer Research
2025;
14
(12)
:8737-8746
.
(31 December 2025)
Demethylzeylasteral alleviates myeloid leukemia through PERK/eIF2α/ATF4/CHOP-mediated cell apoptosis
Translational Cancer Research
2025;
14
(12)
:8747-8764
.
(31 December 2025)
The prognostic role of radiotherapy in non-surgical gastric cancer: a retrospective cohort study in the SEER database
Translational Cancer Research
2025;
14
(12)
:8765-8777
.
(31 December 2025)
Development and validation of a circulating tumor DNA-based machine learning model for predicting immunotherapy response in non-small cell lung cancer
Translational Cancer Research
2025;
14
(12)
:8778-8791
.
(31 December 2025)
Prognostic chromatin remodeling signature stratifies survival outcomes in lung adenocarcinoma patients
Translational Cancer Research
2025;
14
(12)
:8792-8806
.
(31 December 2025)
OX40L and IL-2 combination strategy for gastric cancer immunotherapy
Translational Cancer Research
2025;
14
(12)
:8807-8824
.
(31 December 2025)
Comprehensive analysis of gene signature linking hypoxia and lactylation for predicting prognosis and immunotherapy response in patients with gastric cancer
Translational Cancer Research
2025;
14
(12)
:8825-8839
.
(31 December 2025)
A novel prognostic and immune-related biomarker KCNC3 in colorectal cancer: a pan-cancer analysis
Translational Cancer Research
2025;
14
(12)
:8840-8858
.
(31 December 2025)
SNX24 serves as a potential prognostic biomarker and a therapeutic target in uterine corpus endometrial carcinoma according to bioinformatics and experimentations
Translational Cancer Research
2025;
14
(12)
:8859-8874
.
(31 December 2025)
Albiflorin enhances the antitumor effects of propofol in hepatocellular carcinoma cells by inhibiting the Wnt/β-catenin signaling activation
Translational Cancer Research
2025;
14
(12)
:8875-8888
.
(31 December 2025)
Transfer RNA-derived fragment tRF-28-P4R8YP9LOND5 as a novel serum biomarker for gastric cancer: diagnostic efficacy and clinicopathological correlations
Translational Cancer Research
2025;
14
(12)
:8889-8907
.
(31 December 2025)
Construction of a prognostic model based on efferocytosis for predicting survival and immunotherapy efficacy in cervical cancer
Translational Cancer Research
2025;
14
(12)
:8908-8929
.
(31 December 2025)
Combination of Naples prognostic score and pathological factors for evaluating the long-term prognosis of patients with late-onset colorectal cancer: a multicenter machine learning study
Translational Cancer Research
2025;
14
(12)
:8930-8948
.
(31 December 2025)
Tumor-associated neutrophils drive liver-specific metastatic progression in breast cancer through methionine metabolism mediated by methionine adenosyltransferase II alpha
Translational Cancer Research
2025;
14
(12)
:8949-8964
.
(31 December 2025)
The influence of CXCL9 on M2 macrophages in lung cancer development
Translational Cancer Research
2025;
14
(12)
:8965-8978
.
(31 December 2025)
Neutrophil-to-lymphocyte ratio as a prognostic predictor in adrenocortical carcinoma: a retrospective cohort study stratified by cortisol secretion status
Translational Cancer Research
2025;
14
(12)
:8979-8989
.
(31 December 2025)
Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin’s lymphoma patients treated with chemotherapy: a randomised trial (NCT05834751)
Translational Cancer Research
2025;
14
(12)
:8990-9001
.
(31 December 2025)
Targeting CLIC6 with theaflavin enhances radiotherapy sensitivity in ER+/HER2− breast cancer
Translational Cancer Research
2025;
14
(12)
:9002-9014
.
(31 December 2025)
Case Series
Diagnostic challenges and clinical management of inflammatory myofibroblastic tumor: a retrospective case series study
Translational Cancer Research
2025;
14
(12)
:9015-9026
.
(31 December 2025)
Review Article
Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscape
Translational Cancer Research
2025;
14
(12)
:9027-9052
.
(31 December 2025)
An updated review on systemic therapy for brain metastases in non-small cell lung cancer
Translational Cancer Research
2025;
14
(12)
:9053-9062
.
(31 December 2025)
The role of microRNAs in gastritis, intestinal metaplasia, and gastric cancer: a narrative review
Translational Cancer Research
2025;
14
(12)
:9063-9081
.
(31 December 2025)
Case Report: iMDT Corner
Successful treatment of lung squamous cell carcinoma with envafolimab, a PD-L1 inhibitor combined with chemotherapy: a case report
Translational Cancer Research
2025;
14
(12)
:9082-9090
.
(31 December 2025)
Case Report
Catheter-directed thrombectomy combined with angioplasty and stent implantation for superior vena cava syndrome: a case report
Translational Cancer Research
2025;
14
(12)
:9091-9098
.
(31 December 2025)
Erratum
Erratum: Neuroepithelial cell transforming 1 as a key regulator in non-small cell lung cancer: unveiling causal links and therapeutic potentials
Translational Cancer Research
2025;
14
(12)
:9099
.
(31 December 2025)
